Revenue Growth and Sequential Momentum
Revenue of $1.07 billion in Q1 met the midpoint of guidance and marked the fourth consecutive quarter of sequential growth, representing a 10% year-over-year increase.
Strong Earnings Performance
Non-GAAP diluted EPS of $1.78 met the high end of guidance and non-GAAP operating margin was 5.8%, consistent with guidance despite near-term investments.
Material New Program Wins
Secured 22 new manufacturing programs worth $283 million in annualized revenue when fully ramped; Aerospace & Defense wins were $220 million (record quarterly performance).
Robust Opportunity Funnel
Funnel of qualified manufacturing opportunities remains strong at $3.6 billion; Aerospace & Defense engineering solutions funnel achieved an all-time high.
Upgraded Near-Term Guidance and FY Upside
Q2 revenue guidance of $1.11B–$1.15B (midpoint = +6% sequential, +15% YoY). Company sees potential to meet or exceed the high end of its 9%–12% fiscal 2026 revenue growth target.
Sector Highlights: Healthcare and Aerospace
Healthcare/Life Sciences revenue increased 10% sequentially in Q1 with $40M in wins; company expects Healthcare and Aerospace & Defense sectors each to exceed the 9%–12% fiscal 2026 growth target.
Strong Capital Efficiency and Return
Delivered a return on invested capital of 13.2%, 420 basis points above weighted average cost of capital; ended Q1 in a net cash position with $440M available on the revolver.
Reaffirmed Free Cash Flow and Strategic CapEx
Reconfirmed fiscal 2026 free cash flow target of approximately $100M while guiding capital spending to $100M–$120M to support growth and automation investments.
Operational and Automation Initiatives
Progressing automation (AutoStore, robotics) and AI initiatives across sites with ROIs under 12 months for certain robot deployments; redeployed 7 SMT lines to improve asset utilization and reduce footprint needs.
Site-Level Margin Tailwinds
New Thailand facility expected to contribute ~25–30 basis points of margin improvement for the year; Malaysia site issues were small and expected to be near breakeven by Q2.